Agilent Technologies

A US Health Care Life Sciences Tools & Services
S&P 500
$146.93
+2.66%
Delayed · cached 15 min

Fair value analysis

A
Agilent Technologies
Health CareLife Sciences Tools & Services
$146.93
Close used for this calculation
$77.67Fair value
Financial DNA Score
Profitability · Returns · Balance Sheet · Efficiency · Growth
52/100
Profitability17/25
Returns10/25
Balance Sheet19/25
Efficiency6/25
Growth3/25
Good
Quality radar
52Prof.17/25Ret.10/25Eff.6/25B.Sht19/25Growth3/25

Consensus fair value

$77.67
Above FV
▼ -47.1% against the close used
Model range $45.20 – $91.40
The lowest and highest of the models that produced a value. This is the spread of the methods, not a price target.

Price target range & 52-week position

Bear$45.20Fair value$77.67Bull$91.40
FairClose
52-week traded range
52W low $110.2452W high $159.00

The 52-week range is measured from the stored price history, not estimated.

Valuation summary

Trading above the consensus fair value

Agilent Technologies closed at $146.93, 89.2% above the consensus fair value of $77.67 drawn from 8 valuation models.

Financial DNA score 52/100 — Good. P/E of 32.2x against the 20x sector multiple the P/E model uses.

Quantitative summary only — not investment advice.

All valuation models

DCF Valuation
$80.20
-45.4%
Σ[CF×(1+g)^n/(1.10)^n] + TV/(1.10)^10
g=9%, r=10%, tg=3%, n=10yr
Graham Number
$51.71
-64.8%
√(22.5 × EPS × BVPS)
EPS=4.57, BVPS=26.01 · outside Graham range (P/E 32.2, P/B 5.7) — asset-light, treat as a rough floor
P/E Fair Value
$91.40
-37.8%
EPS × 20x (sector P/E)
EPS=4.57, Sector P/E=20x
Peter Lynch (PEG)
$45.20
-69.2%
EPS × Growth% (PEG = 1 is fair)
EPS=4.57, g=9.9%
EV/EBITDA
$87.13
-40.7%
(EBITDA × 14.9x − Net Debt) ÷ Shares
EBITDA=1.77B
Book Value (P/B)
$76.07
-48.2%
BVPS × (ROE−g)÷(r−g) [Justified P/B — RIM-based]
BVPS=26.01, ROE=17.7%, g=6%, r=10%
Reverse DCF
$146.93
+0.0%
Solve for g: Price = Σ[EPS×(1+g)^n/(1.10)^n] + TV
Implied: 13.5% | Historical: 9.9%
Margin of Safety
$55.83
-62.0%
Avg(DCF, Graham, P/E) × 75% (25% safety buffer)
Avg fair value=74.44, MoS=25%

Computed on September 12, 2026 from the most recent annual report on file and that day's closing price. Where a company has seen its earnings move sharply since its last annual report, this figure will lag the market.

Educational data only. Not a recommendation to buy, sell or hold any security.

Educational data only. Not a recommendation to buy, sell or hold any security.